(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






BlackRock Posts Mixed Q3 Earnings; Bullish View On Immunovant

  • October 13th, 2023
  • 657 views

BlackRock, Inc. (NYSE: BLK), an investment management and financial services company, reported third-quarter 2023 adjusted earnings per share (EPS) of $10.91, surpassing the consensus EPS estimate of $8.26. However, the company's revenue for the period stood at $4.522 billion, slightly below analysts' expectations of $4.54 billion.

$BLK was trading at $630.00 in pre-market, reflecting a decrease of $6.17 (-0.97%).

In other news, UBS has upgraded Immunovant, Inc. (Nasdaq: IMVT), a biopharmaceutical company, from Neutral to Buy and raised the price target from $18 to $55.

Despite closing at $35.28 on Thursday, the adjusted price target indicates a potential upside of $19.72 or about 55.86% for $IMVT, based on the financial services firm's analysis

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Tags

Social Shares

Post Your Comments

Want To Find Some News?

Recent Posts

News By Industries

Tags